Skip to main content
. Author manuscript; available in PMC: 2015 Jul 24.
Published in final edited form as: Am J Physiol Heart Circ Physiol. 2005 Jun 17;289(5):H1951–H1959. doi: 10.1152/ajpheart.00194.2005

Table 1.

Patient dimensions and hemodynamic data

Control POTS
Weight, kg 72±5 69±4
Height, cm 167±4 167±3
Body surface area, m2 1.76±0.09 1.70±0.05
Normalized blood volume, ml/kg 65±5 68±6
Cardiac index (by ICG), l· min−1·m−2 3.5±0.5 4.3±0.6
Total peripheral resistance, mmHg·l−1·min·m2 31±4 23±5
Venous occlusion calf blood flow, ml·100 ml−1·min−1 2.3±0.4 2.7±0.3
HR phase 0, beats/min 63±5 81±3*
Systolic BP phase 0, mmHg 118±5 120±3
MAP phase 0, mmHg 82±4 89±4
Impedance blood flows phase 0, ml/min
  Thoracic 5,805±824 4,975±720
  Splanchnic 1,245±220 2,247±366*
  Pelvic 662±171 618±127
  Leg 112±18 93±14
% Change in blood volume during Valsalva maneuver
  Thoracic −9±1 −29±8*
  Splanchnic 6±1 20±8*
  Pelvic 2±1 1±1
  Leg 1±1 1±1

Values are means ± SE. POTS, postural tachycardia syndrome; ICG, indocyanine green; HR, heart rate; BP, blood pressure; MAP, mean arterial pressure.

*

P < 0.05 difference compared with control subjects.